1. Biographies

   Announcement 29 January 2015 Pages: 1 - 1

   

2. Preface

   • Michael A. Tainsky
   • Robert T. Morris

   EditorialNotes 04 February 2015 Pages: 3 - 3

3. Primary debulking surgery and neoadjuvant chemotherapy in the treatment of advanced epithelial ovarian carcinoma

   • Shelly M. Seward
   • Ira Winer

   OriginalPaper 18 January 2015 Pages: 5 - 10

   

4. Maintenance chemotherapy in the management of epithelial ovarian cancer

   • Maurie Markman

   OriginalPaper 08 January 2015 Pages: 11 - 17

5. Anti-vascular therapies in ovarian cancer: moving beyond anti-VEGF approaches

   • Hyun-Jin Choi
   • Guillermo N. Armaiz Pena
   • Anil K. Sood

   OriginalPaper 30 December 2014 Pages: 19 - 40

6. Role of the folate receptor in ovarian cancer treatment: evidence, mechanism, and clinical implications

   • Ignace B. Vergote
   • Christian Marth
   • Robert L. Coleman

   OriginalPaper 07 January 2015 Pages: 41 - 52

   

7. RETRACTED ARTICLE: Targeted immune therapy of ovarian cancer

   • Keith L. Knutson
   • Lavakumar Karyampudi
   • Claudia Preston

   OriginalPaper 30 December 2014 Pages: 53 - 74

   

8. Exploring alternative ovarian cancer biomarkers using innovative nanotechnology strategies

   • Cesar M. Castro
   • Hyungsoon Im
   • Michael J. Birrer

   OriginalPaper 28 December 2014 Pages: 75 - 82

   

9. Proteomics of ovarian cancer: functional insights and clinical applications

   • Mohamed A. Elzek
   • Karin D. Rodland

   OriginalPaper 04 March 2015 Pages: 83 - 96

10. The conflicting roles of tumor stroma in pancreatic cancer and their contribution to the failure of clinical trials: a systematic review and critical appraisal

    • Maarten F. Bijlsma
    • Hanneke W. M. van Laarhoven

    Clinical 08 January 2015 Pages: 97 - 114

    

11. Immunotherapy of melanoma: Present options and future promises

    • Anand Rotte
    • Madhuri Bhandaru
    • Kevin J. McElwee

    Clinical 15 January 2015 Pages: 115 - 128

    

12. Low immunogenicity in non-small cell lung cancer; do new developments and novel treatments have a role?

    • R. E. Gardiner
    • S. Jahangeer
    • J. Hinchion

    Clinical 01 March 2015 Pages: 129 - 144

13. Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring

    • Andrew McGuire
    • James A. L. Brown
    • Michael J. Kerin

    Clinical Open access 27 February 2015 Pages: 145 - 155

    

14. HER2 expression status in diverse cancers: review of results from 37,992 patients

    • Min Yan
    • Maria Schwaederle
    • Razelle Kurzrock

    Clinical Open access 25 February 2015 Pages: 157 - 164

    

15. Erratum to: Microenvironmental acidosis in carcinogenesis and metastases: new strategies in prevention and therapy

    • Stefano Fais
    • Giulietta Venturi
    • Robert A. Gatenby

    Erratum 28 November 2014 Pages: 165 - 165